NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis

Author(s): Lin Daniel W, Coleman Ilsa M, Hawley Sarah, Dumpit Ruth, Gifford David, Kezele Philip, Hung Hau, Knudsen Beatrice S, Kristal Alan R, Nelson Peter S

Publication: Journal of Clinical Oncology, 2006, Vol. 24, Page 3763

PubMed ID: 16822846 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine if gene expression can be influenced by variables associated with surgical resection, including warm ischemia time, blood loss amount, and total surgical duration, or influenced by patient-related parameters, such as age, prostate-specific antigen levels, and prostate gland volume.

Conclusion of Paper

Surgical manipulation during radical prostatectomy significantly altered the expression of 1.5% of the cDNAs examined, translating to 62 affected genes. Alterations in gene expression were limited to upregulation in biospsy specimens procured after surgical resection when compared to control biopsies procured in situ, and ranged in magnitude from 2- to 14-fold. Of the clinical and surgical variables investigated, prostate gland volume alone influenced the magnitude of change observed between biopsies procured pre- and post-resection.

Studies

  1. Study Purpose

    The purpose of this study was to determine if gene expression, as measured by cDNA microarray, is altered following surgical resection. Biospies were collected in situ from the prostate prior to vascular clamp placement or ex vivo after radical prostatectomy in twelve patients.

    Summary of Findings:

    Of the 5,753 cDNAs examined by cDNA microarray, 88 cDNAs representing 62 genes were altered in biopsies obtained from surgically resected specimens compared to biopsies procured in situ prior to vascular clamp placement. The false-discovery rate was estimated to be approximately 10%. Affected genes included several that are involved in acute phase response, IER2 and JUNB, cell proliferation regulation, P21Cip1 and KLF6, as well as those associated with the JNK stress-response pathway. No transcripts exhibiting a significant reduction in expression following surgical resection were observed.

    Biospecimens
    Preservative Types
    • OCT
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    RNA DNA microarray
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Method of tissue acquisition Biopsy
    Surgical resection
  2. Study Purpose

    The purpose of this study was to determine if expression of a subset of genes identified by microarray (of DUSP1, KLF6, and AMACR) in fact differ among case-matched biopsy specimens procured in situ before vascular clamp placement or ex vivo after radical prostatectomy. A total of 8 cores were obtained from each of the 12 patients assessed.

    Summary of Findings:

    Quantitative RT-PCR (qRT-PCR) analysis revealed that DUSP1 and KLF6 expression were significantly upregulated, by 14- and 4-fold respectively, in biopsy specimens procured after surgical resection compared to those collected before vascular clamp placement. AMACAR expression did not differ significantly among biopsy specimens collected pre-and post-resection. QRT-PCR results are consistent with those reported for microarray.

    Biospecimens
    Preservative Types
    • OCT
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    RNA Real-time qRT-PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Real-time qRT-PCR Specific Targeted nucleic acid DUSP1
    KLF6
    AMACR
    Biospecimen Acquisition Method of tissue acquisition Biopsy
    Surgical resection
  3. Study Purpose

    The purpose of this study was to examine the potential influence of patient-related variables (including patient age, prostate gland volume, prostate-specific antigen concentration), and surgery-related factors (including warm ischemia time, estimated blood loss amount, and surgical duration) on gene expression as measured by microarray. Microarray analysis was limited to a subset of 62 genes that displayed differential expression as a result of time of procurement, pre- versus post-surgical resection. Four core biopsies were obtained from each of the 12 patients assessed before vascular clamp placement and again after completion of a radical prostatectomy.

    Summary of Findings:

    Statistically relevant correlations between clinical and operative variables and gene expression were limited to prostate gland volume. The magnitude of change induced by surgical resection when compared to biopsies taken in situ was negatively correlated to prostate gland volume for 55 (or 89%) of the 62 genes examined, translating to smaller differences in transcript expression for larger prostate gland volumes. Conversely, age, PSA concentration, total operative time, warm ischemia time, and estimated blood loss were not associated with differences in gene expression, although statistical power was modest.

    Biospecimens
    Preservative Types
    • OCT
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    RNA DNA microarray
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Blood loss amount 450 ml
    600 ml
    650 ml
    700 ml
    800 ml
    950 ml
    1000 ml
    1100 ml
    1500 ml
    1600 ml
    2100 ml
    Preaquisition Warm ischemia time 19 min
    20 min
    25 min
    26 min
    27 min
    29 min
    30 min
    33 min
    35 min
    36 min
    40 min
    Preaquisition Patient age 53
    59
    60
    62
    64
    65
    67
    68
    69
    Preaquisition Biomarker level 2.5 ng/dL
    3.5 ng/dL
    4.2 ng/dL
    4.6 ng/dL
    4.7 ng/dL
    5.0 ng/dL
    5.4 ng/dL
    5.6 ng/dL
    6.3 ng/dL
    8.2 ng/dL
    16.0 ng/dL
    Preaquisition Surgery duration 164 min
    176 min
    180 min
    185 min
    187 min
    196 min
    201 min
    203 min
    210 min
    221 min
    237 min
    Biospecimen Acquisition Organ measurements Prostate gland volume (31 ml)
    35 ml
    36 ml
    37 ml
    39 ml
    43 ml
    49 ml
    50 ml
    65 ml
    78 ml
    149 ml

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...